Scientists from the universities in Münster and Munich have discovered what precisely goes wrong in the body in the case of multiple sclerosis (MS). At the same time the neuroscientists were able to demonstrate that for MS, which occurs in bouts, there is a therapy which is tailor-made to eliminate the deficit.
The researchers involved are talking of a milestone: neuroimmunologists and neuropathologists from the universities in Münster and Munich have discovered what precisely goes wrong in the body in the case of multiple sclerosis (MS). Cells in the innate immune system – the natural killer cells (NK cells) – no longer fulfil their function with MS.
They cannot sufficiently keep in check the effector T cells, which are the cells that cause damage in the body in the case of MS. At the same time the neuroscientists were able to demonstrate that for MS, which occurs in bouts, there is a therapy which is tailor-made to eliminate the deficit – a blockade of the interleukin-2 receptor.
The drug used for this – Daclizumab – has just been recommended for approval by the European Medicines Agency EMA, so patients will soon be able to use it in their therapy. The effects of the new drug have already been demonstrated in clinical studies, in which the Münster neuroimmunologists were also involved. Their results, achieved in Collaborative Research Centre TR128 (“Multiple Sclerosis”), can be seen in the latest issue of the prestigious journal “Proceedings of the National Academy of Sciences”.
A healthy immune system functions like an efficient police check on traffic: anyone found speeding – in this case, autoreactive T lymphocytes – are singled out and punished. On the other hand, just the threat of a traffic fine is sufficient to prevent the majority of drivers from speeding.
This is how people posing a potential threat to others are held in check. In the case of multiple sclerosis, however, this check does not function properly. Autoreactive T cells cross the blood-brain barrier unhindered and pass into the brain, where they attack the nerve cells’ protective layer. Using the traffic image again: anyone speeding is not stopped and they cause serious accidents.
Project leaders Dr. Catharina Groß and Prof. Heinz Wiendl from the Department of General Neurology at Münster University Hospital demonstrated that cells from the body’s innate immune system – the NK cells – help decisively to keep dangerous autoreactive cells in check in healthy people. The researchers were even able to decipher the precise molecular mechanism which NK cells use to protect the immune system.
They also revealed that, in the case of MS, not only do the monitoring mechanisms of the immune system fail, but the harmful T cells also use tricks to evade any control on the part of the natural killer cells – just as if traffic offenders were to remove the number plates from their car so as not to be identified.
And one more thing the scientists showed was that there is a promising drug – Daclizumab, a monoclonal antibody – to counteract the interleukin-2 receptor and strengthen the immune-regulatory function of the NK cells. Support, so to speak, in monitoring the traffic. “We were able to demonstrate that Daclizumab not only reinforces the positive immune-regulatory function of the natural killer cells,“ says Dr. Groß, whose work was supported with funding from the German Research Foundation (DFG).
Together with her colleagues, one of the things she did was to analyse blood from patients with multiple sclerosis who had already been treated with the new substance. This substance, she says, leads to the harmful T cells again becoming more receptive to regulation by the NK cells. The European Medicines Agency EMA recommended at the end of April that the substance be approved after successful Phase II and Phase III studies on MS patients.
Research successes like this one need not only the expertise of neuroimmunologists in Münster, as Prof. Heinz Wiendl, who heads both the project and a working group, stresses. What progressed the project in particular was the collaboration with neuroscientists Prof. Reinhard Hohlfeld and Dr. Klaus Dornmair from Munich University and Prof. Tanja Kuhlmann from the Department of Neuropathology at Münster University. All these people work together as part of Collaborative Research Centre TR128 (“Multiple Sclerosis”), funded by the German Research Foundation. The Centre’s translational platform provided the blood and cerebrospinal fluid samples from patients which required for analysis.
Gross CC, Schulte-Mecklenbeck A, Rünzi A, Kuhlmann T, Posevitz-Fejfár A, Schwab N, Schneider-Hohendorf T, Herich A, Held K, KonjeviM, Hartwig M, Dornmair K, Hohlfeld R, Ziemssen T, Klotz L, Meuth SG, Wiendl H, Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation. PNAS 2016; published ahead of print May 9, 2016, doi:10.1073/pnas.1524924113
Dr. Thomas Bauer
http://www.pnas.org/content/early/2016/05/04/1524924113.abstract?sid=50ecc138-88... Original publication (PNAS)
Dr. Christina Heimken | idw - Informationsdienst Wissenschaft
GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University
Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
24.04.2018 | Information Technology
24.04.2018 | Earth Sciences
24.04.2018 | Life Sciences